Literature DB >> 21775727

Beneficial role of Nrf2 in regulating NADPH generation and consumption.

Kai Connie Wu1, Julia Yue Cui, Curtis D Klaassen.   

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that promotes the transcription of cytoprotective genes in response to oxidative and electrophilic stresses. Most functions of Nrf2 were identified by studying biological models with Nrf2 deficiency, however, little is known about the effects of graded Nrf2 activation. In the present study, genomic gene expression profiles by microarray analysis were characterized with a "gene dose-response" model in livers of Nrf2-null mice, wild-type mice, Kelch-like ECH associating protein 1 (Keap1)-knockdown (Keap1-KD) mice with enhanced Nrf2 activation, and Keap1-hepatocyte knockout (Keap1-HKO) mice with maximum hepatic Nrf2 activation. Hepatic nuclear Nrf2 protein, glutathione concentrations, and known Nrf2 target genes were increased in a dose-dependent manner. In total, 115 genes were identified to be constitutively induced and 80 genes suppressed with graded Nrf2 activation. Messenger RNA of genes encoding enzymes in the pentose phosphate pathway and enzyme were low with Nrf2 deficiency and high with Nrf2 activation, indicating that Nrf2 is important for NADPH production. NADPH is the major reducing resource to scavenge oxidative stress, including regenerating glutathione and thioredoxin and is also used for anabolic pathways including lipid synthesis. High performance liquid chromatography-ultraviolet absorbance analysis confirmed that hepatic NADPH concentration was lowest in Nrf2-null mice and highest in Keap1-HKO mice. In addition, genes involved in fatty acid synthesis and desaturation were downregulated with graded Nrf2 activation. In conclusion, the present study suggests that Nrf2 protects against environmental insults by promoting the generation of NADPH, which is preferentially consumed by aiding scavenging of oxidative stress rather than fatty acid synthesis and desaturation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775727      PMCID: PMC3179677          DOI: 10.1093/toxsci/kfr183

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  46 in total

1.  Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.

Authors:  Jutta Lamlé; Silke Marhenke; Jürgen Borlak; Reinhard von Wasielewski; C J Peter Eriksson; Robert Geffers; Michael P Manns; Masayuki Yamamoto; Arndt Vogel
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

2.  Sites of alkylation of human Keap1 by natural chemoprevention agents.

Authors:  Yan Luo; Aimee L Eggler; Dongting Liu; Guowen Liu; Andrew D Mesecar; Richard B van Breemen
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-02       Impact factor: 3.109

3.  Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells.

Authors:  Hongqiao Zhang; Albert Shih; Alessandra Rinna; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2008-10-22       Impact factor: 4.013

4.  NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet.

Authors:  Yuji Tanaka; Lauren M Aleksunes; Ronnie L Yeager; Maxwell A Gyamfi; Noriko Esterly; Grace L Guo; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2008-02-15       Impact factor: 4.030

5.  Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice.

Authors:  Avantika Barve; Tin Oo Khor; Sujit Nair; Wen Lin; Siwang Yu; Mohit Raja Jain; Jefferson Y Chan; Ah-Ng Kong
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

6.  Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.

Authors:  Kosuke Okada; Junichi Shoda; Keiko Taguchi; Jonathan M Maher; Kaoru Ishizaki; Yoshimi Inoue; Makio Ohtsuki; Nobuharu Goto; Koichi Takeda; Hirotoshi Utsunomiya; Koji Oda; Eiji Warabi; Tetsuro Ishii; Keiko Osaka; Ichinosuke Hyodo; Masayuki Yamamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-07       Impact factor: 4.052

7.  The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Authors:  Matthew D Merrell; Jonathan P Jackson; Lisa M Augustine; Craig D Fisher; Angela L Slitt; Jonathan M Maher; Wendong Huang; David D Moore; Youcai Zhang; Curtis D Klaassen; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

Review 8.  Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.

Authors:  Lauren M Aleksunes; José E Manautou
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

9.  Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.

Authors:  Scott A Reisman; Ronnie L Yeager; Masayuki Yamamoto; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-01-06       Impact factor: 4.849

Review 10.  Curcumin and cancer: an "old-age" disease with an "age-old" solution.

Authors:  Preetha Anand; Chitra Sundaram; Sonia Jhurani; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Cancer Lett       Date:  2008-05-06       Impact factor: 8.679

View more
  126 in total

1.  ESCRT-III-dependent membrane repair blocks ferroptosis.

Authors:  Enyong Dai; Lingjun Meng; Rui Kang; Xiaofeng Wang; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2019-11-21       Impact factor: 3.575

Review 2.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

Review 3.  Serine and one-carbon metabolism in cancer.

Authors:  Ming Yang; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 4.  Targeting NAD+ Metabolism to Enhance Radiation Therapy Responses.

Authors:  Joshua E Lewis; Naveen Singh; Reetta J Holmila; Baran D Sumer; Noelle S Williams; Cristina M Furdui; Melissa L Kemp; David A Boothman
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 5.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

Review 6.  Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease.

Authors:  Xingguo Zhu; Aluya R Oseghale; Lopez H Nicole; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-23

Review 7.  ROS in Cancer: The Burning Question.

Authors:  Iok In Christine Chio; David A Tuveson
Journal:  Trends Mol Med       Date:  2017-04-17       Impact factor: 11.951

8.  Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Treated Mice Demonstrates NRF2-Independent PKM2 Induction.

Authors:  Rance Nault; Claire M Doskey; Kelly A Fader; Cheryl E Rockwell; Tim Zacharewski
Journal:  Mol Pharmacol       Date:  2018-05-11       Impact factor: 4.436

9.  Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells.

Authors:  Piul S Rabbani; Marc A Soares; Sophia G Hameedi; Rohini L Kadle; Adnan Mubasher; Maria Kowzun; Daniel J Ceradini
Journal:  Diabetes       Date:  2018-10-23       Impact factor: 9.461

10.  Predictors of mitochondrial DNA copy number and damage in a mercury-exposed rural Peruvian population near artisanal and small-scale gold mining: An exploratory study.

Authors:  Axel J Berky; Ian T Ryde; Beth Feingold; Ernesto J Ortiz; Lauren H Wyatt; Caren Weinhouse; Heileen Hsu-Kim; Joel N Meyer; William K Pan
Journal:  Environ Mol Mutagen       Date:  2018-10-05       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.